IFM Therapeutics Competitors and Similar CompaniesClear all
IFM Therapeutics's competitors and similar companies include Kiromic Biopharma, RAPT Therapeutics, Beta Pharma and OncoArendi Therapeutics.
 Kiromic Biopharma Kiromic BioPharma (formerly known as Kiromic) is a target discovery and gene editing company focusing on developing immuno-oncology therapeutics for the treatment of blood cancers and solid tumors. |  RAPT Therapeutics RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents. |  Beta Pharma Beta Pharma is a specialty pharmaceutical company dedicated to the discovery, development, and commercialization of late stage therapies targeting oncology. |  OncoArendi Therapeutics OncoArendi Therapeutics is a biotech company focused on discovery and development of small molecule drug candidates. | ||
Founding Date | Founding Date 2017 | Founding Date 2012 | Founding Date 2015 | Founding Date 1996 | Founding Date 2012 |
Type | Type Private | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Boston, US HQ | Locations Houston, US HQ | Locations South San Francisco, US HQ | Locations Princeton, US HQ | Locations Warszawa, PL HQ Łódź, PL |
Employees | Employees 12 | Employees 4426% increase | Employees 64 | Employees 36 | Employees 839% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.8 m | Valuation ($) 69.8 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Net income | Net income N/A | Net income ($26.9m) (FY, 2024) | Net income ($129.9m) (FY, 2024) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 82.5m | Total funding raised $ 135k | Total funding raised $ 176m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Kiromic Biopharma
HQ
Houston, US
Employees
44↑ 26% increase
Kiromic BioPharma (formerly known as Kiromic) is a target discovery and gene editing company focusing on developing immuno-oncology therapeutics for the treatment of blood cancers and solid tumors.
View companyRAPT Therapeutics
HQ
South San Francisco, US
Employees
64
RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents.
View companyBeta Pharma
HQ
Princeton, US
Employees
36
Beta Pharma is a specialty pharmaceutical company dedicated to the discovery, development, and commercialization of late stage therapies targeting oncology.
View companyOncoArendi Therapeutics
HQ
Warszawa, PL
Employees
83↑ 9% increase
OncoArendi Therapeutics is a biotech company focused on discovery and development of small molecule drug candidates.
View company